Description
CJC-1295 with DAC Overview
CJC-1295 with DAC is a synthetic 30-amino-acid peptide. It was derived from the first 29 residues of growth hormone-releasing hormone (GHRH), modified at four positions, and conjugated to a Drug Affinity Complex (DAC) that binds to serum albumin.
Since its development in the early 2000s, it has been studied extensively in controlled experimental settings. Research has focused on its potential influence on GHRH-receptor signaling, growth hormone secretion and IGF-1 dynamics. The albumin-binding DAC is what separates it from the shorter-acting CJC-1295 No DAC.
CJC-1295 with DAC Research Focus
Published laboratory and preclinical work on CJC-1295 with DAC has concentrated on the following areas:
- GHRH-receptor signaling
- Growth hormone secretion in experimental models
- IGF-1 dynamics
- Effect of albumin binding on duration of activity
Available Formats
CJC-1295 with DAC is available in 5mg vials. Each strength can be ordered as a single vial or as a pack of 10 vials; choose your options above before adding to the cart.
Handling and Storage
Store and handle CJC-1295 with DAC according to the product label and your laboratory’s standard operating procedures. For background on the factors that affect stability, such as temperature, moisture, light and repeated freeze-thaw cycles, read our guide to peptide storage and stability.
Reference
Jetté L. et al. (2005). Find this reference on PubMed.
Related Research Peptides
Browse the full Growth Hormone Axis Peptides range or search the shop.
For research use only. CJC-1295 with DAC is intended exclusively for legitimate laboratory research. It is not for human or veterinary consumption and is not a drug, food, supplement or cosmetic. Nothing on this page is medical advice. By purchasing, the buyer agrees to use this product in compliance with all applicable laws.
Reviews
There are no reviews yet.